EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tumor Electric Field Therapy Inhibits Epithelial‐Mesenchymal Transition, Invasion, and Migration of Glioblastoma by Targeting the c‐ FOS / CXCL14 Axis

Cheng Sun, Yuyang Liu, Junyi Chen iD, Jie Pei, Chao Li, Jinxin Lan, Er Wen, Jialin Liu, Ze Li iD, Ling Chen

CNS Neuroscience & Therapeutics · 2026-05 · 32 (5)

DOI: 10.1002/cns.70926 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 19.05.2026. Verfasst von Cheng Sun und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical School of, Chinese PLA, Beijing, China. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Proto-Oncogene Proteins c-fos, Brain Neoplasms, Glioblastoma. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glioblastoma (GBM) is among the most aggressive and treatment‐resistant primary brain tumors. The mesenchymal subtype of GBM shows a particularly unfavorable prognosis. Epithelial‐mesenchymal transition (EMT) is a critical phenotypic characteristic of this subtype. Tumor electric field therapy (TEFT) has emerged as a promising adjuvant therapy, but its underlying anti‐GBM mechanisms remain incompletely elucidated.

Methods

Key molecular targets of TEFT were identified through integrated multi‐omics data analysis. U87, U251, and T98G cell lines received TEFT treatment at 200 kHz and 2.2 V/cm for 72 h. Stable cell models with CXCL14 and c‐FOS knockdown or overexpression were established using lentiviral vectors. Cellular phenotypes were assessed via wound healing assays, transwell migration and invasion assays, and western blot analysis. The regulatory hierarchy between c‐FOS and CXCL14 was verified via chromatin immunoprecipitation (ChIP) assays and rescue experiments. Mechanistic insights were validated in orthotopic nude mouse models and clinical patient specimens.

Results

CXCL14 was identified by integrated bioinformatics analysis. It showed significant overexpression in mesenchymal subtypes and was strongly associated with poor prognosis. Single‐cell sequencing analysis suggested a significant increase in the EMT score of the subgroup with high CXCL14 expression. TEFT induced a morphological shift from mesenchymal to epithelial‐like characteristics. It downregulated mesenchymal markers, including N‐cadherin, Vimentin, and Snail, while upregulating E‐cadherin. Mechanistic investigations demonstrated that TEFT promoted the degradation of c‐FOS, leading to CXCL14 downregulation and subsequent inhibition of EMT. In vivo experiments confirmed the critical role of the c‐FOS/CXCL14 axis in regulating GBM invasion and migration potential.

Conclusion

This study first revealed a novel mechanism which TEFT suppressed EMT in GBM via the c‐FOS/CXCL14 axis. These findings provided a new therapeutic target and a theoretical foundation for optimizing TEFT efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionProto-Oncogene Proteins c-fosBrain NeoplasmsGlioblastomaCell MovementChemokines, CXCHumansAnimalsCell Line, TumorMice, NudeNeoplasm InvasivenessMiceGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

CXCL14c‐FOSepithelial‐mesenchymal transitionglioblastomatumor electric field therapy

Substanzen

Proto-Oncogene Proteins c-fosChemokines, CXCCXCL14 protein, humanFOS protein, human

Autor:innen und Institutionen

  • Medical School of, Chinese PLA, Beijing, China.
  • Department of Neurosurgery, Chinese PLA General Hospital, Beijing, China.
  • Ninth Medical Center of, Chinese PLA General Hospital, Beijing, China.
  • Department of Neurosurgery, 920th Hospital of Joint Logistics Support Force, Kunming, China.
  • Graduate School, Kunming Medical University, Kunming, China.
  • Department of Neurosurgery, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.

ORCID-Profile: Junyi Chen, Ze Li

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Sun, C., Liu, Y., Chen, J., Pei, J., Li, C., Lan, J., Wen, E., Liu, J., Li, Z., & Chen, L. (2026). Tumor Electric Field Therapy Inhibits Epithelial‐Mesenchymal Transition, Invasion, and Migration of Glioblastoma by Targeting the c‐ FOS / CXCL14 Axis. CNS Neuroscience & Therapeutics, 32(5). https://doi.org/10.1002/cns.70926

Vancouver

Sun C, Liu Y, Chen J, Pei J, Li C, Lan J, et al. Tumor Electric Field Therapy Inhibits Epithelial‐Mesenchymal Transition, Invasion, and Migration of Glioblastoma by Targeting the c‐ FOS / CXCL14 Axis. CNS Neuroscience & Therapeutics. 2026;32(5). doi:10.1002/cns.70926

BibTeX
@article{Sun2026,
  author = {Sun, Cheng and Liu, Yuyang and Chen, Junyi and Pei, Jie and Li, Chao and Lan, Jinxin and Wen, Er and Liu, Jialin and Li, Ze and Chen, Ling},
  title = {Tumor Electric Field Therapy Inhibits Epithelial‐Mesenchymal Transition, Invasion, and Migration of Glioblastoma by Targeting the c‐ FOS / CXCL14 Axis},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2026},
  volume = {32},
  number = {5},
  doi = {10.1002/cns.70926}
}
Kostenlos starten →